List of Triptodur Kit drug patents
Triptodur Kit is owned by Arbor Pharms Llc.
Triptodur Kit contains Triptorelin Pamoate.
Triptodur Kit has a total of 1 drug patent out of which 0 drug patents have expired.
Triptodur Kit was authorised for market use on 29 June, 2017.
Triptodur Kit is available in for suspension, extended release;intramuscular dosage forms.
The generics of Triptodur Kit are possible to be released after 30 June, 2029.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10166181 | ARBOR PHARMS LLC | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(6 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity (ODE) | Jun 29, 2024 |
Drugs and Companies using TRIPTORELIN PAMOATE ingredient
Market Authorisation Date: 29 June, 2017
Treatment: NA
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
TRIPTODUR KIT family patents
4
European Union
3
United States
2
Poland
2
Slovenia
2
Lithuania
2
RS
2
Denmark
2
Croatia
2
IB
2
Hungary
2
Spain
2
Portugal
2
Cyprus
1
ME
1
Canada
1
Korea, Republic of
1
Ukraine
1
Brazil
1
Hong Kong
1
China
1
Morocco
1
Japan
1
Malaysia
1
AP
1
Mexico
1
New Zealand
1
EA
1
Australia
1
Colombia
1
South Africa
1
Tunisia
1
Israel
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic